MSD is reported to have been negotiating with Swiss biotech MoonLake Immunotherapeutics over a takeover deal – estimated to be worth more than $3 billion – according to media reports. The Financial ...
MSD's efforts to combine cancer immunotherapy Keytruda with its AstraZeneca-partnered PARP drug Lynparza have so far failed – but at last it can point to a partial win in a phase 3 trial. The new data ...
Jason Fernando is a professional investor and writer who enjoys tackling and communicating complex business and financial problems. Natalya Yashina is a CPA, DASM with over 12 years of experience in ...
The Legend of Hei II, the sequel to the 2019 animated blockbuster, surprised China's box office revenues on Friday when it beat director Jiang Wen's You Are the Best and Da Peng's The Lychee Road. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback